BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6821010)

  • 1. Diabetic and galactosaemic cataracts.
    James M; Crabbe C; Harding JJ
    Trans Ophthalmol Soc U K (1962); 1982; 102 Pt 3():342-5. PubMed ID: 6821010
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetic and galactosaemic cataracts.
    Kador PF; Kinoshita JH
    Ciba Found Symp; 1984; 106():110-31. PubMed ID: 6439498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etiology of cataracts in diabetics.
    Varma SD; Richards RD
    Int Ophthalmol Clin; 1984; 24(4):93-110. PubMed ID: 6438012
    [No Abstract]   [Full Text] [Related]  

  • 4. [The role of polyol pathways in formation of diabetic cataracts].
    Sabasiński K; Andrzejewska-Buczko J
    Klin Oczna; 1997; 99(6):401-4. PubMed ID: 9685789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sugar alcohols in the pathogenesis of galactose and diabetic cataracts.
    van Heyningen R
    Birth Defects Orig Artic Ser; 1976; 12(3):295-303. PubMed ID: 821562
    [No Abstract]   [Full Text] [Related]  

  • 6. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS; Ghosh MN
    Indian J Physiol Pharmacol; 1981; 25(3):193-200. PubMed ID: 6795119
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitory effect of lycopene on cataract development in galactosemic rats.
    Pollack A; Madar Z; Eisner Z; Nyska A; Oren P
    Metab Pediatr Syst Ophthalmol (1985); 1996-1997; 19-20():31-6. PubMed ID: 11548783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyol accumulation in galactosemic and diabetic rats: control by an aldose reductase inhibitor.
    Dvornik E; Simard-Duquesne N; Krami M; Sestanj K; Gabbay KH; Kinoshita JH; Varma SD; Merola LO
    Science; 1973 Dec; 182(4117):1146-8. PubMed ID: 4270794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of G-6-PD deficiency, experimentally induced or genetically transmitted, on the sorbitol pathway activity. In vitro and in vivo studies.
    Vaca G; Ramírez MG; Vargas M; Mendoza R; Chávez-Anaya E; Medina MD; Alvarez A; Medina C; Sáenz G; Chávez M
    Arch Med Res; 1992; 23(1):25-32. PubMed ID: 1308788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactitol accumulation and irreversible lens opacities in galactosemic rats.
    Simard-Duquesne N; Dvornik D
    Invest Ophthalmol; 1973 Jan; 12(1):82-3. PubMed ID: 4691951
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes of some biochemical parameters of the lens in galactose-treated weaned rats with and without vitamin E therapy.
    Libondi T; Menzione M; Iuliano G; Della Corte M; Latte F; Auricchio G
    Ophthalmic Res; 1985; 17(1):42-8. PubMed ID: 3920597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic cataracts- is aldose reductase important?
    Crabbe MJ; Wolff S; Halder AB; Ting HH
    Metab Pediatr Ophthalmol; 1981; 5(1):33-8. PubMed ID: 6789018
    [No Abstract]   [Full Text] [Related]  

  • 13. The lens, cataracts, and galactosemia.
    Cogan DG
    N Engl J Med; 1973 Jun; 288(23):1239-40. PubMed ID: 4700558
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo effectiveness of sulindac in sugar cataracts--the implication.
    Sharma YR; Bhatnagar R; Vajpayee RB; Mohan M; Gupta SK; Mukesh K
    Dev Ophthalmol; 1989; 17():173-5. PubMed ID: 2507366
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of development and possible prevention of sugar cataracts.
    Gabbay KH; Kinoshita JH
    Isr J Med Sci; 1972; 8(8):1557-61. PubMed ID: 4647820
    [No Abstract]   [Full Text] [Related]  

  • 16. The lens and cataract in diabetes.
    Bron AJ; Brown NA; Harding JJ; Ganea E
    Int Ophthalmol Clin; 1998; 38(2):37-67. PubMed ID: 9604737
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical studies on the etiology of cataract in diabetes].
    Friedburg D; Mayer U
    Ber Zusammenkunft Dtsch Ophthalmol Ges; 1970; 70():362-8. PubMed ID: 5537496
    [No Abstract]   [Full Text] [Related]  

  • 18. Galactose tolerance in patients with atopic cataracts.
    Muhlemann MF; Mount JN; Cream JJ
    Br J Dermatol; 1987 Jul; 117(1):37-41. PubMed ID: 3651334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens.
    Lee AY; Chung SK; Chung SS
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2780-4. PubMed ID: 7708723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sugar metabolism in the crystalline lens.
    Chylack LT; Cheng HM
    Surv Ophthalmol; 1978; 23(1):26-37. PubMed ID: 100892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.